Brought to you by 
Lineagen raises $15.8mm in Series C financing
05 Mar 2015
Executive Summary
Lineagen Inc., which sells the autism molecular diagnostic FirstStepDx Plus and is developing tests for MS and COPD, raised $15.8mm in Series C financing in two tranches ($3.63mm and $12.17mm).
Deal Industry
- In Vitro Diagnostics
- Services
-
In Vitro Diagnostics
- Cytology
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Lineagen raises $15.8mm in Series C financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice